HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.

Abstract
Malignant glioma cells are generally resistant or only weakly sensitive to tumor necrosis factor family of cell death-inducing ligands, including TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L. The chemopreventive activity of polyphenolic compounds present in plant-derived food products has been well recognized in epidemiological studies; however, the mechanism of chemoprevention by these dietary constituents largely remains unknown. Curcumin, the yellow pigment in the spice turmeric, has profound anti-inflammatory activity and exhibits chemopreventive and tumor growth inhibitory activity. In the present study, we investigated whether curcumin sensitizes malignant glioma cell lines U251MG and U87MG to TRAIL-induced apoptosis. Treatment with low concentrations (5-20 microM) of curcumin alone had no effect on the viability of either cell line. At low concentration (5 ng/ml) TRAIL induced cytotoxicity in U251MG cells but not in U87MG cells. Whereas curcumin at subtoxic concentration sensitized U87MG cells to TRAIL-induced cytotoxicity, it had no effect on TRAIL-mediated cytotoxicity in U251MG cells. The combined curcumin and TRAIL treatment enhanced accumulation of hypo-diploid U87MG cells in sub G1 cell cycle phase and induced the cleavage of procaspases-3, -8, -9 and release of cytochrome c from mitochondria. These data indicate that curcumin differentially sensitizes glioma cells to TRAIL-induced apoptosis through the activation of both extrinsic (receptor-mediated) and intrinsic (chemical-induced) pathways of apoptosis. These results define a potential use of curcumin to sensitize glioma cells for TRAIL-mediated immunotherapy.
AuthorsXiaohua Gao, Dorrah Deeb, Hao Jiang, Yong B Liu, Scott A Dulchavsky, Subhash C Gautam
JournalJournal of experimental therapeutics & oncology (J Exp Ther Oncol) Vol. 5 Issue 1 Pg. 39-48 ( 2005) ISSN: 1359-4117 [Print] United States
PMID16416600 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • Indicators and Reagents
  • Membrane Glycoproteins
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Tumor Necrosis Factor-alpha
  • Cytochromes c
  • L-Lactate Dehydrogenase
  • CASP3 protein, human
  • CASP8 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases
  • Curcumin
Topics
  • Antineoplastic Agents
  • Apoptosis (drug effects)
  • Apoptosis Regulatory Proteins (genetics)
  • Blotting, Western
  • Brain Neoplasms (pathology)
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases (metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Curcumin
  • Cytochromes c (metabolism)
  • Enzyme Activation
  • Glioma (pathology)
  • Humans
  • Indicators and Reagents
  • L-Lactate Dehydrogenase (metabolism)
  • Membrane Glycoproteins (genetics)
  • Mitochondria (drug effects, enzymology)
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Necrosis Factor-alpha (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: